Byline: GREG BOLT The Register-Guard
The University of Oregon has agreed to share technology and materials developed in its labs with a San Diego-based biotechnology company looking for new treatments for disease and age-related disorders.
The company, MitoKor, will gain access to protein separation technologies and monoclonal antibodies developed for the study of mitochondrial DNA.
Mitochondria are the biological engines that produce the energy that keeps cells alive, and MitoKor specializes in commercial applications of mitochondrial medicine.
Financial terms were not disclosed. Don Gerhard, director of technology transfer for the UO, said the …